Clinical Trials on Neuroma

Total 1450 results

1ST Biotherapeutics, Inc.

Not yet recruiting

A Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418

Amyotrophic Lateral Sclerosis (ALS) | Parkinson Disease Psychosis
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France; Association...

Recruiting

Cell Signaling, Reinnervation and Metabolism in Kennedy Disease and Amyotrophic Lateral Sclerosis (ALS) (CERMALS)

Amyotrophic Lateral Sclerosis | Kennedy Disease

France
Scholar Rock, Inc.

Completed

An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy (TOPAZ)

Neuromuscular Diseases | Neuromuscular Manifestations | Atrophy | Muscular Atrophy | Spinal Muscular Atrophy | Muscular Atrophy, Spinal | Spinal Muscular Atrophy Type 3 | SMA | Spinal Muscular Atrophy Type 2

United States, Spain, Italy, Netherlands
University Hospital, Basel, Switzerland

Enrolling by invitation

Spinal Cord Gray Matter Imaging in Spinal Muscular Atrophy

Spinal Muscular Atrophy Type II | Spinal Muscular Atrophy Type III

Switzerland
Assistance Publique - Hôpitaux de Paris

Completed

Trial Evaluating the Interest of Noninvasive Ventilation in NAVA Mode in Respiratory Decompensations Children With Infantile Spinal Muscular Atrophy Type II (NAVASI)

Infantile Spinal Muscular Atrophy

France
Association pour le Développement et l'Organisation...
Association Française du Syndrome d'Ondine; Fonds de Recherche en Santé Respiratoire

Completed

Cognitive Consequences of an Activation of the Cortical Drive to Breath (VENTIPSY) (VENTIPSY)

Healthy | Amyotrophic Lateral Sclerosis | Ondine Syndrome

France
Ramathibodi Hospital
AstraZeneca

Completed

Effect of Goserelin (Zoladex®) in Spinal and Bulbar Muscular Atrophy

Spinobulbar Muscular Atrophy | Kennedy's Disease

Thailand
National Institute of Neurological Disorders and...

Completed

Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA)

Spinal and Bulbar Muscular Atrophy | Kennedy's Disease

United States
Westat
National Institute of Neurological Disorders and Stroke (NINDS)

Terminated

Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III (NPTUNE01)

Spinal Muscular Atrophy Type II | Spinal Muscular Atrophy Type III

United States
IRCCS Centro Neurolesi "Bonino-Pulejo"

Completed

Optimization and Harmonization of Advanced MRI Sequences

Dementia Alzheimers | Neuro-Degenerative Disease | Lewy Body Variant of Alzheimer Disease | Dementia Frontal

Italy
Marco Capogrosso
Roche-Genentech

Not yet recruiting

Spinal Cord Stimulation for the Treatment of Motor Deficits in People With Spinal Muscular Atrophy - Upper Limb

Spinal Muscular Atrophy | Spinal Muscular Atrophy Type 3 | SMA | Spinal Muscular Atrophy Type II | Spinal Muscular Atrophy 4

United States
Synaptrix Labs Inc.

Not yet recruiting

EMPOWER Early Feasibility Study: Non-invasive BCI to Control a Wheelchair for People With Paralysis

Paralysis | Amyotrophic Lateral Sclerosis | Spinal Cord Injuries | Neurologic Disorder | Cervical Spinal Cord Injury | Paralysis; Stroke | Tetraplegic; Paralysis | Quadriplegia/Tetraplegia

United States
Bahçeşehir University

Not yet recruiting

Public AttitudesTowards SMA and DMD Awareness, Newborn and Carrier Screening and Physiotherapy Practices

Duchenne Muscular Dystrophy | Spinal Muscular Atrophy | Healthy Individuals
Scholar Rock, Inc.

Active, not recruiting

Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam (SAPPHIRE)

Neuromuscular Diseases | Neuromuscular Manifestations | Atrophy | Muscular Atrophy | Spinal Muscular Atrophy | Muscular Atrophy, Spinal | Spinal Muscular Atrophy Type 3 | SMA | Spinal Muscular Atrophy Type 2 | Anti-myostatin

United States, Germany, Belgium, Spain, United Kingdom, Netherlands, France, Italy, Poland
Wave Life Sciences Ltd.

Terminated

Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD) (FOCUS-C9)

ALS | FTD

Canada, Belgium, New Zealand, Netherlands, Australia, Sweden, United Kingdom, Ireland
Wake Forest University Health Sciences

Completed

COVID-19 Amyotrophic Lateral Sclerosis (ALS) Registry

Covid19 | Amyotrophic Lateral Sclerosis

United States
Nationwide Children's Hospital
Novartis

Active, not recruiting

Body Weight Support Harness System in Spinal Muscular Atrophy

Spinal Muscular Atrophy Type II | Spinal Muscular Atrophy Type I

United States
Assistance Publique - Hôpitaux de Paris

Completed

Pilot Study of an Innovative Physiotherapy in Patients With Infantile Spinal Muscular Atrophy (SMA) (ExerASI)

Infantile Spinal Muscular Atrophy of Type 2 or 3

France
China Medical University Hospital

Unknown

Study of the Role of G72 in Amyotrophic Lateral Sclerosis: Biomarker Discovery and Mechanism Investigation

Parkinson's Disease | Amyotrophic Lateral Sclerosis | Alzheimer Disease
Zimmer Biomet

Completed

A Post Market Clinical Follow-up Study on Biomet Microfixation HTR PEKK (Midface), Facial & Mandibular Plates.

Tumor | Neuroma | Mandibular Fractures | Treacher Collins Syndrome | Facial Fracture | Fibrous Dysplasia | Hemifacial Microsomia | Miller Syndrome | Osteoma of Mandibular Condyle | Cleft Face | Nager Syndrome

Argentina
Novartis Pharmaceuticals

Completed

RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe (RAMSETE/CDE16)

Carcinoma | Neuroendocrine | Advanced and Metastatic Silent Neuro-Endocrine Tumors | Non Functioning Neuroendocrine Tumors (NETs) | Non Syndromic Neuroendocrine Tumors | Carcinoids | Non Functioning

Sweden, Italy, Germany, United Kingdom, Spain, France, Netherlands, Poland
Mitsubishi Tanabe Pharma Corporation

Completed

Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions

Behcet Syndrome | Behcet's Disease | Neuro-Behcet's Disease

Japan
National Institute of Neurological Disorders and...

Completed

Natural History and Biomarkers of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Caused by the C9ORF72 Gene Mutation

Amyotrophic Lateral Sclerosis | Frontotemporal Lobar Degeneration

United States
Wave Life Sciences Ltd.

Terminated

Open-label Extension (OLE) Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) and/or Frontotemporal Dementia (FTD)

ALS | FTD

Netherlands, United Kingdom
Transposon Therapeutics, Inc.

Active, not recruiting

A Phase 2a Study of TPN-101 in Patients With C9ORF72 ALS/FTD

Amyotrophic Lateral Sclerosis | Frontotemporal Dementia

Spain, United States, Belgium, France, Germany
University of Missouri-Columbia
National Institute on Deafness and Other Communication Disorders (NIDCD)

Completed

A Systematic Investigation of Phonetic Complexity Effects on Articulatory Motor Performance in Progressive Dysarthria

Parkinson Disease | Amyotrophic Lateral Sclerosis

United States
Hill-Rom

Completed

MN4000 for Treatment of CF and MND Patients in the Home Setting

Motor Neuron Disease | Cystic Fibrosis | Airway Clearance Impairment

United States
Tehran University of Medical Sciences

Unknown

Allogeneic Adipose Derived Stem Cells for Werdnig Hoffman Patients

Infantile Spinal Muscular Atrophy, Type I [Werdnig- Hoffman]

Iran, Islamic Republic of
Assistance Publique - Hôpitaux de Paris

Terminated

Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

Amyotrophic Lateral Sclerosis | Frontotemporal Dementia

France
Johns Hopkins University
National Institute of Neurological Disorders and Stroke (NINDS)

Recruiting

Investigation on the Cortical Communication (CortiCom) System (CortiCom)

Amyotrophic Lateral Sclerosis | Tetraplegia | Locked-in Syndrome | Brainstem Stroke

United States
Scholar Rock, Inc.

Active, not recruiting

Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab-ONYX (ONYX)

Neuromuscular Diseases | Neuromuscular Manifestations | Atrophy | Muscular Atrophy | Spinal Muscular Atrophy | Muscular Atrophy, Spinal | Spinal Muscular Atrophy Type 3 | SMA | Anti-myostatin | Spinal Muscular Atrophy Type II

United States, Spain, Belgium, Germany, Netherlands, Poland, Italy, France, United Kingdom
MarsiBionics
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon...

Completed

Exoskeleton Impact on the Quality of Life on Patients With Spinal Muscular Atrophy

Spinal Muscular Atrophy Type II

Spain
Istituto Clinico Humanitas
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta; Fondazione Salvatore...

Completed

Anti-Cholinergic Receptors Antibodies, Autonomic Profile and Dysautonomia Symptoms in PAF, ALS and POTS (DISAUT-AB) (DISAUT-AB)

Amyotrophic Lateral Sclerosis | Postural Orthostatic Tachycardia Syndrome | Pure Autonomic Failure | Anti-Cholinergic Receptors Antibodies

Italy
Beth Israel Deaconess Medical Center
Merz Pharmaceuticals

Withdrawn

Incobotulinum Toxin A for Sialorrhea in Parkinson's Disease (PD)/Parkinsonism and Amyotrophic Lateral Sclerosis (ALS) (Xeomin)

Parkinson Disease | Amyotrophic Lateral Sclerosis

United States
Children's Oncology Group
National Cancer Institute (NCI)

Recruiting

Project: Every Child for Younger Patients With Cancer

Malignant Solid Neoplasm | Neuroendocrine Neoplasm | Myeloproliferative Neoplasm | Desmoid Fibromatosis | Lymphoproliferative Disorder | Carcinoma In Situ | Central Nervous System Neoplasm | Ganglioneuroma | Congenital Mesoblastic Nephroma | Childhood Immature Teratoma | Childhood Langerhans Cell Histiocytosis and other conditions

United States, Puerto Rico, Canada, Australia, New Zealand, Saudi Arabia
Merve Kurt

Recruiting

Feasibility of Virtual Reality in Children With Neuromuscular Disease, Effectiveness of Virtual Reality and Biofeedback

Duchenne Muscular Dystrophy | Virtual Reality | Spinal Muscular Atrophy | Neuromuscular Disease | Biofeedback

Turkey
Novartis Gene Therapies

Active, not recruiting

Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi

SMA | Spinal Muscular Atrophy Type II | Spinal Muscular Atrophy Type I | Spinal Muscular Atrophy Type III

United States, Belgium, France, Japan, United Kingdom, Italy, Taiwan, Australia, Canada
Columbia University
Muscular Dystrophy Association; Stevens Institute of Technology

Completed

Wearable Technology to Assess Gait Function in SMA and DMD

Duchenne Muscular Dystrophy | Spinal Muscular Atrophy Type 3

United States
Beth Israel Deaconess Medical Center
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Innovative Ultrasound Technology in Neuromuscular Disease (AQUIRe)

Amyotrophic Lateral Sclerosis | Muscular Dystrophy | Radiculopathy | Trauma Injury | Orthopedic Disorder | Myopathy | Polyneuropathy and Mononeuropathies

United States
Cambridge Respiratory Innovations Limited
Innovate UK

Completed

The General Breathing Record Study (GBRS)

Heart Failure | Pneumonia | Motor Neuron Disease | Asthma | Vocal Cord Dysfunction | Breathlessness

United Kingdom
Duke University

Completed

Feasibility of a Consumer Based Accelerometer in Monitoring Outpatient Physical Activity: A Study in Patients With Cancer and Amyotrophic Lateral Sclerosis

Prostate Cancer | Brain Cancer | ALS | Renal Cancer

United States
Thomas Jefferson University

Recruiting

NuroSleeve Powered Brace & Stimulation System to Restore Arm Function

Stroke | Cerebral Palsy | Amyotrophic Lateral Sclerosis | Muscular Dystrophies | Spinal Cord Injuries | Hemiparesis | Spinal Muscular Atrophy | Quadriplegia | Arthrogryposis | Neurologic Diseases | Charcot-Marie-Tooth | Weakness of Extremities as Sequela of Stroke | Weakness Due to Upper Motor Neuron Dysfunction | Arm Paralysis

United States
University of Edinburgh
NHS Lothian

Not yet recruiting

Digital App for Speech & Health Monitoring

Multiple Sclerosis | Parkinson Disease | Motor Neuron Disease | Dementia
Wake Forest University Health Sciences

Withdrawn

Establishment of a Human Tissue Bank for Studying the Microbial Etiology of Neurodegenerative Diseases

Multiple Sclerosis | Parkinson Disease | Neurodegenerative Diseases | Amyotrophic Lateral Sclerosis

United States
National Institute of Neurological Disorders and...

Completed

Effect of Functional Exercise in Patients With Spinal Bulbar Muscular Atrophy

Motor Neuron Disease

United States
University of South Carolina

Completed

Escitalopram (Lexapro) for Depression MS or ALS

Multiple Sclerosis | Amyotrophic Lateral Sclerosis | Major Depression

United States
Jose Luis Urcelay Segura

Unknown

Relationship Between Neurological Disability and Visual Impairment in Patients With ALS or Friedreich's Ataxia

Amyotrophic Lateral Sclerosis

Spain
MinYoung Kim, M.D.

Completed

Combination Therapy of Cord Blood and G-CSF for Patients With Brain Injury or Neurodegenerative Disorders

Cerebral Palsy | Parkinson's Disease | Brain Injury | Amyotrophic Lateral Sclerosis

Korea, Republic of
Hoffmann-La Roche
Association Française contre les Myopathies (AFM), Paris

Completed

Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients.

Spinal Muscular Atrophy Type II | Spinal Muscular Atrophy Type III Non Ambulant

Germany, Italy, France, Belgium, Poland, Netherlands, United Kingdom
National Taiwan University Hospital
National Science Council, Taiwan

Unknown

Reciprocating Gait Orthoses for Paraplegia Patients (UPGO)

Spinal Muscular Atrophy | Spinal Cord Injury | Myelomeningocele

Taiwan

Clinical Trials on Neuroma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations